Contessa Health, Inc., a Nashville, TN-based provider of episodic risk arrangements and home hospitalization programs has $7 million in funding led by Noro-Moseley Partners. The round also included participation from existing investors BlueCross BlueShield Venture Partners, Martin Ventures and Sandbox Advantage Fund, as well as new investors, Nashville Capital Network and the Marshfield Clinic Health System. The startup plans to utilize the latest funding round to scale its operations to expand into new markets.
Founded in 2015 by Travis Messina, Contessa Health creates and manages episodic risk arrangements for Commercial and Medicare Advantage health plans. By combining proprietary platform ContradoClaim™ with evidence-based clinical protocols and managed services, the company aims to enable both payers and providers to operate prospective episodic risk programs. Contessa Health has experienced significant demand from leading health plans and health systems due to its unique ability to provide both clinical support to providers and administrative services and technology to payers.
“The healthcare system is rapidly shifting from traditional fee-for-service to alternative payment models such as bundles,” said Spence McClelland, partner at Noro-Moseley. “Contessa’s home hospitalization programs and technology platform help providers and plans achieve lower costs, better clinical outcomes and a better patient experience under these new models. We are excited to back such an excellent management team and to join a great group of investment syndicate partners.”
